Showing 1691-1700 of 3223 results for "".
- Aerie Pharmaceuticals Receives Marketing Authorization of Roclanda in Great Britainhttps://modernod.com/news/aerie-pharmaceuticals-receives-marketing-authorisation-of-roclanda-in-great-britain/2479089/Aerie Pharmaceuticals announced that Roclanda 50 micrograms/ml + 200 micrograms/ml eye drops solution (latanoprost + netarsudil) has received marketing authorization from the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain. Roclanda is indicated for the reduction of el
- LKC Technologies Launches New UTAS Systems at ARVOhttps://modernod.com/news/lkc-technologies-launches-new-utas-systems-at-arvo/2476520/LKC Technologies has announced the launch of new UTAS systems at the ARVO meeting in Vancouver (booth #1003). The UTAS SunBurst is a small, lightweight and easy to use system capable of conducting full ISCEV-complaint electroretinograms (ERGs), visual evoked potential (VEPs) tests, and ele
- Study: Implandata’s Eyemate System Protects Glaucoma Patients–Even During Lockdownhttps://modernod.com/news/study-implandatas-eyemate-system-protects-glaucoma-patients-even-during-lockdown/2478767/Patients with glaucoma are at high risk of losing their eyesight if their disease progresses undetected and essential therapy adjustments are delayed. On the other hand, these typically elderly, vulnerable individuals are often hampered in seeing their doctor for office visits, particularly durin
- Alcon Expands Surgical Offerings with Portfolio of Mydriatic, Cycloplegic, Diagnostic, and Anesthetic Productshttps://modernod.com/news/alcon-expands-surgical-offerings-with-portfolio-of-mydriatic-cycloplegic-diagnostic-and-anesthetic-products/2479801/Alcon announced that it is expanding its surgical offerings with the addition of a group of products fundamental to many ophthalmic procedures done in the clinic and operating room. These products, which include mydriatic, cycloplegic, diagnostic, and anesthetic products, were transferred from Al
- Alcon Introduces Enhanced WaveLight Refractive Suitehttps://modernod.com/news/alcon-introduces-enhanced-wavelight-refractive-suite/2479821/Alcon unveiled software and hardware enhancements to the WaveLight Refractive Suite designed to provide surgeons and patients a more comfortable and efficient LASIK experience. The new platform offers a modernized user interface, ergonomic design, and expanded equipment color options. “Al
- Study Indicates a Potential Treatment for Corneal Endothelial Disease, Reducing the Need for Corneal Transplantshttps://modernod.com/news/study-indicates-a-potential-treatment-for-corneal-endothelial-disease-reducing-the-need-for-corneal-transplants/2482045/Findings from a study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte–stimulating hormone (&al
- International Ophthalmology Study Sheds Light on Myopia Biometry Ahead of Refractive Surgeryhttps://modernod.com/news/international-ophthalmology-study-sheds-light-on-myopia-biometry-ahead-of-refractive-surgery/2485825/Key Takeaways The axial length–to–corneal radius (AL/CR) ratio demonst
- Orbis Flying Eye Hospital Begins 2-Week Training Project to Improve Eye Care Across Rwandahttps://modernod.com/news/orbis-flying-eye-hospital-begins-two-week-training-project-to-improve-eye-care-across-rwanda/2482898/The Orbis Flying Eye Hospital landed in Kigali, Rwanda, on July 18, 2025, marking the beginning of a historic 2-week training project. It marks the first time this aircraft has visited Rwanda, where Orbis' teams of clinical staff and volunteer faculty will work alongside t
- Opthea Treats Final Patient in Phase 3 COAST Trial for Wet AMDhttps://modernod.com/news/opthea-treats-final-patient-in-phase-3-coast-trial-for-wet-amd/2482668/Opthea announced that it has completed the final week 52 patient visit in COAST, the first of two phase 3 pivotal trials investigating the superiority and safety of sozinibercept in combination with aflibercept (COAST) or ranibizumab (ShORe), compared to standard of care alone for the treatm
- AAO: Home OCT Device Improves Care for AMD Patients, Reduces Costs and Burdenhttps://modernod.com/news/aao-home-oct-device-improves-care-for-amd-patients-reduces-costs-and-burden/2482499/A newly approved home-based OCT device developed by Notel Vision is allowing patients to monitor their own eye health between appointments, providing physicians with crucial data without requiring in-office visits, according to an AAO news release. A study presented today at AAO 2024 suggest